-
Document de presse | 2020.04.30
Revealing how SARS-CoV-2 hijacks human cells; points to drugs with potential to fight COVID-19 and a drug that aids its infectious growth
An international effort including researchers from University of California San Francisco (UCSF), Gladstone Institutes, Icahn School of Medicine at Mount Sinai and Institut Pasteur (Paris) unveils promising compounds for clinical testing against COVID-19. The study, led by UCSF Quantitative Biosciences Institute Director, Nevan Krogan, PhD, reveals that some drugs may fight COVID-19...
-
Document de presse | 2008.10.05
Nobel Prize in Medicine 2008 awarded to Professors Françoise Barré-Sinoussi and Luc Montagnier
The Nobel Prize in Medicine 2008 has been awarded to Professors Françoise Barré-Sinoussi and Luc Montagnier for their discovery of the human immunodeficiency (AIDS) virus in 1983 at the Institut Pasteur, and to Prof. Harald zur Hausen for his discovery of the human papillomavirus, which is responsible for cervical cancer. Press releaseParis, october 6, 2008 “Twenty five...
-
Document de presse | 2007.06.28
Chikungunya: virus target cells identified
Researchers from the Institut Pasteur and CNRS have identified for the first time the target cells of the Chikungunya virus disease (the "stooped man's disease"), which is currently breaking out in India and Gabon. Their results, obtained in collaboration with clinicians from the island of Reunion, were published in PLoS Pathogens and in PLoS ONE. Press release Paris,...
-
Document de presse | 2004.03.17
World Tuberculosis Day (March 24): The Institut Pasteur engaged in the fight
With a third of the world's population infected, 2 million deaths and 8.5 million new cases each year, tuberculosis (TB) is the number two infectious disease in the world after AIDS, without sparing France, where 6300 new cases occurred last year. The prevalence of the resistance to antibiotics and the emergence of multiresistance are worrying at the international level, and is a risk for...
-
Document de presse | 2013.11.04
Two European programs reinforce the fight against emerging diseases
The 31 partners involved in the two major European research programs PREDEMICS and ANTIGONE are to meet for a joint seminar at the Institut Pasteur on November 6th. These two programs will respectively receive €11.7 million and €12 million funding of the European Union over five years to study the emergence mechanisms of infectious diseases in order to strengthen existing treatment and...
-
Document de presse | 2017.12.14
Sanofi and the Institut Pasteur reward five researchers for their major contributions in the service of human health
Paris, France – December 13th 2017 - Sanofi and the Institut Pasteur presented the Sanofi - Institut Pasteur Awards for the sixth year in a row.Five internationally recognized researchers were rewarded for their work in two major fields with implications for global health: Immunology and Microbiology & Infection. The National Junior award winnersDocteur Fabrizia Stavru – Bacteria-Cell...
-
News | 2017.12.18
Five young researchers from the Institut Pasteur International Network attended the 2017 PhD students' ceremony
Like every year since 2013, the Institut Pasteur organized on December 11th a ceremony in honor of the young graduates who defended their PhD thesis during the 2016-2017 academic year. The 2017 edition honored 34 young Pasteurian scientists, 5 of whom completed their thesis in an institution member of the Institut Pasteur International Network."We are pleased and proud to welcome these young...
-
News | 2018.01.23
Neurobiologist Jean-Pierre Changeux tells us the story of the nicotinic acetylcholine receptor
As the Institut Pasteur prepares to celebrate its 130th anniversary on November 14, 2018, we talk to Jean-Pierre Changeux about the discovery of this ion channel-linked neuroreceptor that revolutionized neuroscience. On February, the researcher publishes a paper in Trends in Neuroscience providing an account of how this receptor's ion channel was structurally identified.The nicotinic...
-
News | 2018.06.05
An update on Ebola in the Democratic Republic of the Congo with Arnaud Fontanet, an expert at the Institut Pasteur
For several weeks, the Democratic Republic of the Congo has been facing a new outbreak of the hemorrhagic fever Ebola. Where does this virus come from? What is the latest on the current crisis? An update with Arnaud Fontanet, Professor at the CNAM and Head of the Epidemiology of Emerging Diseases Unit at the Institut Pasteur in Paris. Arnaud Fontanet, Professor at the CNAM and Head of...
-
Document de presse | 2019.02.18
Gene therapy durably reverses congenital deafness in mice
In collaboration with the universities of Miami, Columbia and San Francisco, scientists from the Institut Pasteur, Inserm, CNRS, Collège de France, Sorbonne University and the University of Clermont Auvergne have managed to restore hearing in an adult mouse model of DFNB9 deafness – a hearing disorder that represents one of the most frequent cases of congenital genetic deafness. Individuals with...